New York, New York--(Newsfile Corp. - December 7, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Celsius Holdings, Inc. (NASDAQ: CELH) between February 29, 2024 and September 4, 2024, both dates inclusive (the "Class Period"), of the important January 21, 2025 lead plaintiff deadline.
SO WHAT: If you purchased Celsius common stock during the Class Period you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.
"A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 21, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation."
WHY ROSEN LAW:
We encourage investors to select qualified counsel with a track record of success in leadership roles. Often firms issuing notices do not have comparable experience, resources, or meaningful peer recognition. Many do not actually litigate securities class actions but are merely middlemen that refer clients or partner with law firms that litigate cases.
"The Rosen Law Firm represents investors throughout the globe... Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time."
DETAILS OF THE CASE:
According to the lawsuit, during the Class Period defendants made false and/or misleading statements and/or failed to disclose that:
- Celsius materially oversold inventory to PepsiCo, Inc. ("Pepsi") far in excess of demand...
- Celsius' sales would materially decline in future periods...
- Celsius' sales rate to Pepsi was unsustainable...
- Celsius' business metrics were not as strong as indicated...
- The statements regarding Celsius' outlook were false and misleading at all relevant times.
"When true details entered the market... investors suffered damages."
No Class Has Been Certified. Until a class is certified... You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.